Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
454 participants
INTERVENTIONAL
2009-01-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesis is: if young children in the age of 6 month to 15 mdr. has a daily intake of a suspension containing probiotics in a period of 9 months, the incidence of diarrhoea and respiratory diseases can be reduced.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
NCT02032056
Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare
NCT02180581
Impact of Probiotic Use on Immune Cell Function in Children
NCT02687503
Probiotic for Infants
NCT07054216
Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
NCT00599430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our hypothesis is: if young healthy children in the age of 6 month to 15 mdr. has a daily intake of a suspension containing probiotics( BB12 and TH4) in a period of 9 months, the incidence of diarrhoea and respiratory diseases can be reduced.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
probiotics
placebo
2
probiotics
0,53 ml MCT oil containing BB12 and TH4 in daily dosage in 9 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
probiotics
placebo
probiotics
0,53 ml MCT oil containing BB12 and TH4 in daily dosage in 9 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age \> 36. weeks
Exclusion Criteria
* Short Bowel Syndrome
* CVC (Central Venous Catheter)
6 Months
7 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Holbaek Sygehus
OTHER
Dept. of Microbiology, Slagelse University Hospital, Region Zealand,DK
UNKNOWN
Chr Hansen
INDUSTRY
Ferrosan A/S
UNKNOWN
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paediatr. Depart., Uni. Hosp. Holbaek, Region Zealand,DK, Uni. of CPH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mette L. Gyhrs, MD.
Role: PRINCIPAL_INVESTIGATOR
ph.d student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Paediatr. Depart., University Hospital Holbaek, University of Copenhagen
Holbæk, Region Sjælland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nielsen AC, Gyhrs ML, Nielsen LP, Pedersen C, Bottiger B. Gastroenteritis and the novel picornaviruses aichi virus, cosavirus, saffold virus, and salivirus in young children. J Clin Virol. 2013 Jul;57(3):239-42. doi: 10.1016/j.jcv.2013.03.015. Epub 2013 Apr 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.